Andrew C. Chan's most recent trade in Corvus Pharmaceuticals Inc was a trade of 30,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 23, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Corvus Pharma Inc | Andrew C. Chan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2026 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Bitfarms Ltd | Andrew J. Chang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2026 | 101,010 | 101,010 | - | - | Restricted Stock Units | |
| Lindblad Expeditions Holdings Inc | Andrew Chan Stuart | Director | Grant, award, or other acquisition of securities at price $ 12.36 per share. | 08 Aug 2025 | 8,899 | 23,546 | - | 12.4 | 109,992 | Restricted Stock |
| Lindblad Expeditions Holdings Inc | Andrew Chan Stuart | Director | Grant, award, or other acquisition of securities at price $ 7.51 per share. | 08 Aug 2024 | 14,647 | 14,647 | - | 7.5 | 109,999 | Restricted Stock |